YAP1 and Hepatic fibrosis: A recent mouse study showed how activation of Gα-coupled dopamine receptor D1 inhibits YAP/TAZ function in mesenchymal cells, reversing in vitro ECM stiffening and in vivo lung and liver fibrosis (49).